Innovita Biological Technology Co., Ltd. (SHA:688253)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Diagnostic Kits / Equipment			478.02M	446.62M	326.91M	1.04B	138.01M
Diagnostic Kits / Equipment Growth			7.03%	36.62%	-68.48%	651.46%	75.08%
Total			478.02M	446.62M	326.91M	1.04B	138.01M
Total Growth			7.03%	36.62%	-68.48%	651.46%	75.08%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
East China			-	-	-	184.52M	42.40M
East China Growth			-	-	-	335.15%	76.15%
Northwest China			-	-	-	106.85M	11.04M
Northwest China Growth			-	-	-	867.59%	78.26%
North China			-	-	-	49.94M	18.21M
North China Growth			-	-	-	174.21%	48.26%
Central China			-	-	-	52.18M	13.73M
Central China Growth			-	-	-	280.09%	68.20%
Southwest China			-	-	-	46.01M	17.50M
Southwest China Growth			-	-	-	162.95%	188.73%
Northeast China			-	-	-	41.40M	3.87M
Northeast China Growth			-	-	-	970.95%	78.64%
South China			-	-	-	34.98M	20.46M
South China Growth			-	-	-	70.94%	92.32%
Overseas (including Hong Kong, Macao and Taiwan)			-	-	-	164.11M	9.50M
Overseas (including Hong Kong, Macao and Taiwan) Growth			-	-	-	1626.76%	4.93%
Hong Kong			-	-	-	129.10M	-
Philippines			-	-	-	99.83M	84.67K
Philippines Growth			-	-	-	117800.17%	768.14%
Japan			-	-	-	52.03M	-
Ecuador			-	-	-	43.46M	1.21M
Ecuador Growth			-	-	-	3490.61%	564.38%
Czech			-	-	-	32.70M	-
Total			-	-	-	1.04B	138.01M
Total Growth			-	-	-	651.46%	75.08%

Source: S&P Global Market Intelligence.